SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical : Dexcom
DXCM 165.09+0.9%11:20 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Julius Wong11/21/2017 9:57:23 PM
  Read Replies (1) of 7
 
DexCom teams up with Lilly to combine CGM into insulin lineup
  • DexCom ( DXCM -0.9%) inks a development agreement with Eli Lilly ( LLY +1.2%) to include Dexcom Continuous Glucose Monitoring (CGM) into Lilly's diabetes ecosystem. The companies plan to combine Lilly's smart insulin delivery devices and Dexcom CGM as a comprehensive solution to improve diabetes management. Clinical studies will begin next month.
  • Financial terms are not disclosed.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext